Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.

Kayser G, Schulte-Uentrop L, Sienel W, Werner M, Fisch P, Passlick B, Zur Hausen A, Stremmel C.

Lung Cancer. 2012 Jun;76(3):445-51. doi: 10.1016/j.lungcan.2012.01.004. Epub 2012 Jan 31.

PMID:
22300751
2.

Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer.

Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT.

Clin Cancer Res. 2008 Aug 15;14(16):5220-7. doi: 10.1158/1078-0432.CCR-08-0133.

3.

CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers.

Wakabayashi O, Yamazaki K, Oizumi S, Hommura F, Kinoshita I, Ogura S, Dosaka-Akita H, Nishimura M.

Cancer Sci. 2003 Nov;94(11):1003-9.

4.

Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.

Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, Kudoh S, Ochiai A.

Cancer. 2008 Sep 15;113(6):1387-95. doi: 10.1002/cncr.23712.

5.

CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.

Karagöz B, Bilgi O, Gümüs M, Erikçi AA, Sayan O, Türken O, Kandemir EG, Oztürk A, Yaylaci M.

Med Oncol. 2010 Mar;27(1):29-33. doi: 10.1007/s12032-008-9165-9. Epub 2009 Jan 16.

PMID:
19148592
6.

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH.

Cancer Res. 2001 Jun 15;61(12):4766-72.

7.

The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma.

Al-Shibli K, Al-Saad S, Andersen S, Donnem T, Bremnes RM, Busund LT.

APMIS. 2010 May;118(5):371-82. doi: 10.1111/j.1600-0463.2010.02609.x.

PMID:
20477813
8.

Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.

Esendagli G, Bruderek K, Goldmann T, Busche A, Branscheid D, Vollmer E, Brandau S.

Lung Cancer. 2008 Jan;59(1):32-40. Epub 2007 Sep 7.

PMID:
17825949
9.

Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.

Chaput N, Louafi S, Bardier A, Charlotte F, Vaillant JC, Ménégaux F, Rosenzwajg M, Lemoine F, Klatzmann D, Taieb J.

Gut. 2009 Apr;58(4):520-9. doi: 10.1136/gut.2008.158824. Epub 2008 Nov 20.

PMID:
19022917
10.

CD8+ T cells expressing IL-10 are associated with a favourable prognosis in lung cancer.

Miotto D, Lo Cascio N, Stendardo M, Querzoli P, Pedriali M, De Rosa E, Fabbri LM, Mapp CE, Boschetto P.

Lung Cancer. 2010 Sep;69(3):355-60. doi: 10.1016/j.lungcan.2009.12.012. Epub 2010 Jan 20.

PMID:
20089329
11.

The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.

Al-Shibli K, Al-Saad S, Donnem T, Persson M, Bremnes RM, Busund LT.

Histopathology. 2009 Sep;55(3):301-12. doi: 10.1111/j.1365-2559.2009.03379.x.

PMID:
19723145
12.

Infiltration of CD8+ T cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis.

Mori M, Ohtani H, Naito Y, Sagawa M, Sato M, Fujimura S, Nagura H.

Tohoku J Exp Med. 2000 Jun;191(2):113-8.

13.

Clinical significance of the frequency of regulatory T cells in regional lymph node lymphocytes as a prognostic factor for non-small-cell lung cancer.

Hanagiri T, Shigematsu Y, Shinohara S, Takenaka M, Oka S, Chikaishi Y, Nagata Y, Iwata T, Uramoto H, So T, Tanaka F.

Lung Cancer. 2013 Sep;81(3):475-9. doi: 10.1016/j.lungcan.2013.07.001. Epub 2013 Jul 26.

PMID:
23891508
14.

Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.

Watanabe Y, Katou F, Ohtani H, Nakayama T, Yoshie O, Hashimoto K.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):744-52. doi: 10.1016/j.tripleo.2009.12.015. Epub 2010 Mar 29.

PMID:
20303300
15.

Phenotypic analysis of T lymphocytes isolated from non-small-cell lung cancer.

Riemann D, Wenzel K, Schulz T, Hofmann S, Neef H, Lautenschläger C, Langner J.

Int Arch Allergy Immunol. 1997 Sep;114(1):38-45.

PMID:
9303329
16.

[Clinical significance of CD4+ CD25+ regulatory T-cells detection in tumor-draining lymph nodes of nonsmall cell lung cancer patients].

Su YJ, Ren K, Li H, Ren XB, Wang CL.

Zhonghua Zhong Liu Za Zhi. 2007 Dec;29(12):922-6. Chinese.

PMID:
18478932
17.

Immunologic parameters as significant prognostic factors in lung cancer.

Nakamura H, Saji H, Ogata A, Hosaka M, Hagiwara M, Kawasaki N, Konaka C, Kato H.

Lung Cancer. 2002 Aug;37(2):161-9.

PMID:
12140139
18.

The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN.

Wang YY, He XY, Cai YY, Wang ZJ, Lu SH.

Target Oncol. 2011 Sep;6(3):147-54. doi: 10.1007/s11523-011-0182-9. Epub 2011 May 25.

PMID:
21611754
19.

HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.

Kikuchi E, Yamazaki K, Torigoe T, Cho Y, Miyamoto M, Oizumi S, Hommura F, Dosaka-Akita H, Nishimura M.

Cancer Sci. 2007 Sep;98(9):1424-30. Epub 2007 Jul 23.

20.

Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer.

O'Callaghan DS, Rexhepaj E, Gately K, Coate L, Delaney D, O'Donnell DM, Kay E, O'Connell F, Gallagher WM, O'Byrne KJ.

Eur Respir J. 2015 Dec;46(6):1762-72. doi: 10.1183/13993003.00176-2014. Epub 2015 Nov 5.

Supplemental Content

Support Center